Print PRINT
X

Simple Steps to Mastering Toric IOL Implantation

Connect the Dots provides a step-by-step guide to successful outcomes with AcrySof® IQ Toric IOLs—from mastering the procedure and explaining its benefits to patients, to training and involving your staff. Whether it's simple instruction, engaging "how-to" examples or dynamic video tutorials, this comprehensive resource has everything you need from start to success with toric IOLs.

Learn how simple it is to begin implementing toric IOLs in your practice.

If you’re doing high quality cataract surgery, you’re really already using all the steps and technology you need to achieve good results with a toric lens.”

-Richard Tipperman, MD
Ophthalmic Partners of Pennsylvania*

*Dr. Tipperman is a paid consultant for Alcon.

Get Started with Connect the Dots

  • Patient Identification

    One in two of your cataract patients are in the correctable range of toric IOLs.1

    Recommend Toric IOLs
  • Surgical Planning

    Besides a toric marker set, you have all the tools you need to begin implanting toric IOLs.

    Create a Surgical Plan
  • Toric Procedure

    Marking the eye and aligning the IOL are the only additional steps in a toric procedure.

    Implant Toric Lenses
  • Post-Op Assessment

    Use the post-op assessment to measure your surgical success and further refine your toric IOL technique.

    Evaluate Your Success

Toric IOL Resource Library

Visit the Connect the Dots Resource Library to watch surgical videos, access patient and staff education materials and find additional information about toric IOLs.

View Important Product Information for
AcrySof® IQ Toric IOL+

AcrySof® IQ Toric IOL

Currently AcrySof® IQ Toric IOL is only available in the United States.

CAUTION:
Federal (USA) law restricts this device to the sale by or on the order of a physician.

INDICATIONS:
The AcrySof® IQ Toric posterior chamber intraocular lenses are intended for primary implantation in the capsular bag of the eye for visual correction of aphakia and pre-existing corneal astigmatism secondary to removal of a cataractous lens in adult patients with or without presbyopia, who desire improved uncorrected distance vision, reduction of residual refractive cylinder and increased spectacle independence for distance vision.

WARNING / PRECAUTION:
Careful preoperative evaluation and sound clinical judgment should be used by the surgeon to decide the risk/benefit ratio before implanting a lens in a patient with any of the conditions described in the Directions for Use labeling. Toric IOLs should not be implanted if the posterior capsule is ruptured, if the zonules are damaged, or if a primary posterior capsulotomy is planned. Rotation can reduce astigmatic correction; if necessary lens repositioning should occur as early as possible prior to lens encapsulation. All viscoelastics should be removed from both the anterior and posterior sides of the lens; residual viscoelastics may allow the lens to rotate.

Optical theory suggests that high astigmatic patients (i.e. > 2.5 D) may experience spatial distortions. Possible toric IOL related factors may include residual cylindrical error or axis misalignments. Prior to surgery, physicians should provide prospective patients with a copy of the Patient Information Brochure available from Alcon for this product informing them of possible risks and benefits associated with the AcrySof® IQ Toric Cylinder Power IOLs.

Studies have shown that color vision discrimination is not adversely affected in individuals with the AcrySof® Natural IOL and normal color vision. The effect on vision of the AcrySof® Natural IOL in subjects with hereditary color vision defects and acquired color vision defects secondary to ocular disease (e.g., glaucoma, diabetic retinopathy, chronic uveitis, and other retinal or optic nerve diseases) has not been studied. Do not resterilize; do not store over 45° C; use only sterile irrigating solutions such as BSS® or BSS PLUS® Sterile Intraocular Irrigating Solutions.

ATTENTION:
Reference the Directions for Use labeling for a complete listing of indications, warnings and precautions.

Click here to view the AcrySof® IQ Toric IOL Directions For Use (DFU).
Click here to view the AcrySof® IQ Toric High Cylinder Power Directions For Use (DFU)

AcrySof® IQ Toric IOL

Currently AcrySof® IQ Toric IOL is only available in the United States.

CAUTION:
Federal (USA) law restricts this device to the sale by or on the order of a physician.

INDICATIONS:
The AcrySof® IQ Toric posterior chamber intraocular lenses are intended for primary implantation in the capsular bag of the eye for visual correction of aphakia and pre-existing corneal astigmatism secondary to removal of a cataractous lens in adult patients with or without presbyopia, who desire improved uncorrected distance vision, reduction of residual refractive cylinder and increased spectacle independence for distance vision.

WARNING / PRECAUTION:
Careful preoperative evaluation and sound clinical judgment should be used by the surgeon to decide the risk/benefit ratio before implanting a lens in a patient with any of the conditions described in the Directions for Use labeling. Toric IOLs should not be implanted if the posterior capsule is ruptured, if the zonules are damaged, or if a primary posterior capsulotomy is planned. Rotation can reduce astigmatic correction; if necessary lens repositioning should occur as early as possible prior to lens encapsulation. All viscoelastics should be removed from both the anterior and posterior sides of the lens; residual viscoelastics may allow the lens to rotate.

Optical theory suggests that high astigmatic patients (i.e. > 2.5 D) may experience spatial distortions. Possible toric IOL related factors may include residual cylindrical error or axis misalignments. Prior to surgery, physicians should provide prospective patients with a copy of the Patient Information Brochure available from Alcon for this product informing them of possible risks and benefits associated with the AcrySof® IQ Toric Cylinder Power IOLs.

Studies have shown that color vision discrimination is not adversely affected in individuals with the AcrySof® Natural IOL and normal color vision. The effect on vision of the AcrySof® Natural IOL in subjects with hereditary color vision defects and acquired color vision defects secondary to ocular disease (e.g., glaucoma, diabetic retinopathy, chronic uveitis, and other retinal or optic nerve diseases) has not been studied. Do not resterilize; do not store over 45° C; use only sterile irrigating solutions such as BSS® or BSS PLUS® Sterile Intraocular Irrigating Solutions.

ATTENTION:
Reference the Directions for Use labeling for a complete listing of indications, warnings and precautions.

Click here to view the AcrySof® IQ Toric IOL Directions For Use (DFU).
Click here to view the AcrySof® IQ Toric High Cylinder Power Directions For Use (DFU)